Robinson Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Robinson Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,035	Closed	-$36	–	279
2023 Q3	$36	Sell	4,035 -10,276	-72%	-$1.23K	﹤0.01%	236
2023 Q2	$2.11K	Sell	14,311 -275	-2%	-$28	﹤0.01%	192
2023 Q1	$1.17K	Hold	14,586	–	–	﹤0.01%	237
2022 Q4	$1.46K	Hold	14,586	–	–	﹤0.01%	272
2022 Q3	$1K	Buy	14,586 +1,293	+10%	+$144	﹤0.01%	302
2022 Q2	$1K	Buy	+13,293	New	+$2.48K	﹤0.01%	290

Robinson Capital Management's BIOSW Position: Q4 2023 in Review

Robinson Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 4,035 shares — an estimated $36 sold.

Robinson Capital Management first reported a position in BIOSW in Q2 2022 and held it in 6 quarters. The position peaked at $2.11K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Robinson Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Robinson Capital Management sold 4,035 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $36.
Robinson Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 6 quarters.
Robinson Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $2.11K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Robinson Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.